Zentiva SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zentiva SA with three other pharmaceutical manufacturers in Europe: Olainfarm AS of LATVIA (2019 sales of 137.22 million Euros [US$155.40 million] of which 63% was Medicine Production), Advanced Medical Solutions Group plc of UNITED KINGDOM (£102.37 million [US$129.09 million] of which 55% was Surgical), and Mithra Pharmaceuticals SA which is based in BELGIUM (96.52 million Euros [US$109.31 million] of which 95% was Out-licensing).

Sales Analysis. During the year ended December of 2019, sales at Zentiva SA were 559.01 million Romanian Leu (US$130.85 million). This is an increase of 21.2% versus 2018, when the company's sales were 461.41 million Romanian Leu. This was the fifth consecutive year of sales increases at Zentiva SA (and since 2014, sales have increased a total of 42%).